Russia’s Chumakov Center gets permission for clinical tests of its coronavirus vaccineChristian Fernsby ▼ | September 22, 2020
The Chumakov Federal Scientific Center for Research and Development of Immune and Biological Products at the Russian Academy of Sciences received the Russian health ministry’s permit for clinical tests of its anti-coronavirus vaccine, the ministry’s press service said.
Russia Chumakov Center
Topics: Russia Chumakov
The ministry said the volunteers will receive all the required information about the procedure and possible risks and inconveniencies that it might entail.
After the vaccination, participants will remain in isolation in hospitals for 16 days, where their health will be monitored by doctors.
"We expect to complete the clinical trials in November," the press service quoted Aidar Ishmukhametov, the Center’s director general, as saying. ■